Safety and efficacy outcomes with nivolumab plus ipilimumab in patients with advanced renal cell carcinoma and low Karnofsky performance status: Results from the CheckMate 920 trial.

被引：0
|
作者：
Hutson, Thomas E. [1 ]
Carthon, Bradley Curtis [2 ]
Yorio, Jeffrey [3 ]
Babu, Sunil [4 ]
McKean, Heidi Ann [5 ]
Percent, Ivor John [6 ]
Tykodi, Scott S. [7 ]
Harrison, Michael Roger [8 ]
Zhang, Joshua [9 ]
Zoco, Jesus [10 ]
Johansen, Jennifer L. [9 ]
George, Daniel J. [8 ]
机构：
[1] Texas A&M Coll Med, Bryan, TX USA
[2] Emory Univ Hosp Midtown, Atlanta, GA USA
[3] Texas Oncol, Austin, TX USA
[4] Ft Wayne Med Oncol & Hematol, Ft Wayne, IN USA
[5] Avera Med Grp Oncol & Hematol, Sioux Falls, SD USA
[6] Florida Canc Specialists, Port Charlotte, FL USA
[7] Univ Washington, Seattle, WA 98195 USA
[8] Duke Univ, Duke Canc Inst Ctr Prostate & Urol Canc, Durham, NC USA
[9] Bristol Myers Squibb, Princeton, NJ USA
[10] Syneos Hlth, Braine Lalleud, Belgium
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期
关键词：
D O I：
10.1200/JCO.2021.39.6_suppl.315
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
315
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Safety and efficacy outcomes with nivolumab plus ipilimumab in patients with advanced renal cell carcinoma and brain metastases: results from the CheckMate 920 trial.
    Emamekhoo, Hamid
    Olsen, Mark R.
    Carthon, Bradley Curtis
    Drakaki, Alexandra
    Percent, Ivor John
    Molina, Ana M.
    Cho, Daniel C.
    Bendell, Johanna C.
    Gordan, Lucio N.
    Kalebasty, Arash Rezazadeh
    George, Daniel J.
    Hutson, Thomas E.
    Arrowsmith, Edward
    Zhang, Joshua
    Zoco, Jesus
    Johansen, Jennifer L.
    Leung, David
    Tykodi, Scott S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [2] Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920
    Emamekhoo, Hamid
    Olsen, Mark R.
    Carthon, Bradley C.
    Drakaki, Alexandra
    Percent, Ivor J.
    Molina, Ana M.
    Cho, Daniel C.
    Bendell, Johanna C.
    Gordan, Lucio N.
    Kalebasty, Arash Rezazadeh
    George, Daniel J.
    Hutson, Thomas E.
    Arrowsmith, Edward R.
    Zhang, Joshua
    Zoco, Jesus
    Johansen, Jennifer L.
    Leung, David K.
    Tykodi, Scott S.
    CANCER, 2022, 128 (05) : 966 - 974
  • [3] Nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma (nccRCC): Safety and efficacy from CheckMate 920.
    Tykodi, Scott S.
    Gordan, Lucio N.
    Alter, Robert S.
    Arrowsmith, Edward
    Harrison, Michael Roger
    Percent, Ivor John
    Singal, Rakesh
    Van Veldhuizen, Peter J.
    George, Daniel J.
    Hutson, Thomas E.
    Zhang, Joshua
    Zoco, Jesus
    Johansen, Jennifer L.
    Kalebasty, Arash Rezazadeh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [4] Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trial
    Tykodi, Scott S.
    Gordan, Lucio N.
    Alter, Robert S.
    Arrowsmith, Edward
    Harrison, Michael R.
    Percent, Ivor
    Singal, Rakesh
    Van Veldhuizen, Peter
    George, Daniel J.
    Hutson, Thomas
    Zhang, Joshua
    Zoco, Jesus
    Johansen, Jennifer L.
    Kalebasty, Arash Rezazadeh
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (02)
  • [5] Safety and efficacy of nivolumab plus ipilimumab (NIVO plus IPI) in patients with advanced renal cell carcinoma (aRCC) with brain metastases: Interim analysis of CheckMate 920.
    Emamekhoo, Hamid
    Olsen, Mark
    Carthon, Bradley Curtis
    Drakaki, Alexandra
    Percent, Ivor John
    Molina, Ana M.
    Cho, Daniel C.
    Bendell, Johanna C.
    Gordan, Lucio N.
    Kalebasty, Arash Rezazadeh
    George, Daniel J.
    Hutson, Thomas E.
    Lee, Richard J.
    Young, Tina C.
    Johansen, Jennifer
    Tykodi, Scott S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trial
    George, Daniel J.
    Spigel, David R.
    Gordan, Lucio N.
    Kochuparambil, Samith T.
    Molina, Ana M.
    Yorio, Jeff
    Kalebasty, Arash Rezazadeh
    McKean, Heidi
    Tchekmedyian, Nishan
    Tykodi, Scott S.
    Zhang, Joshua
    Askelson, Margarita
    Johansen, Jennifer L.
    Hutson, Thomas E.
    BMJ OPEN, 2022, 12 (09):
  • [7] Efficacy and safety of nivolumab plus ipilimumab in Asian patients with advanced hepatocellular carcinoma: Subanalysis of the CheckMate 040 study
    Yau, T.
    Hsu, C.
    Kang, Y.
    Kim, T.
    Hou, M.
    Lim, H.
    Chao, Y.
    Kim, Y.
    Ikeda, M.
    Choo, S.
    Neely, J.
    Shen, Y.
    Tschaika, M.
    Kudo, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S233 - S233
  • [8] Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trial
    Yau, Thomas
    Kang, Yoon-Koo
    Kim, Tae-You
    El-Khoueiry, Anthony B.
    Santoro, Armando
    Sangro, Bruno
    Melero, Ignacio
    Kudo, Masatoshi
    Hou, Ming-Mo
    Matilla, Ana
    Tovoli, Francesco
    Knox, Jennifer J.
    He, Aiwu Ruth
    El-Rayes, Bassel F.
    Acosta-Rivera, Mirelis
    Lim, Ho-Yeong
    Neely, Jaclyn
    Shen, Yun
    Wisniewski, Tami
    Anderson, Jeffrey
    Hsu, Chiun
    JAMA ONCOLOGY, 2020, 6 (11)
  • [9] CHECKMATE 040: EFFICACY, HEPATIC SAFETY, AND BIOMARKERS OF NIVOLUMAB plus IPILIMUMAB COMBINATION THERAPY IN PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA
    Sangro, Bruno
    Hsu, Chiun
    Kang, Yoon-Koo
    Kim, Tae-You
    El-Khoueiry, Anthony
    Santoro, Armando
    Melero, Ignacio
    Kudo, Masatoshi
    Hou, Ming-Mo
    Pena, Ana Matilla
    Tovoli, Francesco
    Knox, Jennifer J.
    He, Aiwu Ruth
    El-Rayes, Bassel
    Acosta, Mirelis Rivera
    Lim, Ho-Yeong
    Neely, Jaclyn
    Zhao, Huanyu
    Anderson, Jeffrey
    Yau, Thomas
    HEPATOLOGY, 2019, 70 : 131A - 132A
  • [10] Safety and Efficacy of Nivolumab in Combination With Ipilimumab in Metastatic Renal Cell Carcinoma: The CheckMate 016 Study
    Hammers, Hans J.
    Plimack, Elizabeth R.
    Infante, Jeffrey R.
    Rini, Brian I.
    McDermott, David F.
    Lewis, Lionel D.
    Voss, Martin H.
    Sharma, Padmanee
    Pal, Sumanta K.
    Razak, Albiruni R. Abdul
    Kollmannsberger, Christian
    Heng, Daniel Y. C.
    Spratlin, Jennifer
    McHenry, M. Brent
    Amin, Asim
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (34) : 3851 - +
12345